Intersect ENT Profit Margin

Intersect ENT (XENT) currently reports a profit margin of -163.91% as of March 2022. That compares with -87.96% in the prior-year period — down 86.3% year over year. That is below the Healthcare sector average of 15.29%. Use the charts on this page to explore Intersect ENT's profit margin history and peer comparisons.

Intersect ENT's profit margin decreased from -87.96% to -163.91% — a 86.3% year-over-year decrease (period ending March 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Intersect ENT's profit margin of -163.91% is lower than the Healthcare sector average of 15.29%. That is roughly 1171.8% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Intersect ENT's current -163.91% should be judged against Healthcare norms (sector average: 15.29%) and against XENT's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -163.91%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 15.29%. From there, open related valuation or income-statement pages for Intersect ENT, and consider following XENT for alerts when major investors trade the stock.